Ambroxol — brands & medicines in Pakistan
Pakistan mein Ambroxol ke 1 brands available hain. Drug class: Mucolytic. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Ambroxol is a mucolytic used in Pakistan for Mucolytic — thinning thick mucus (balgam) in acute and chronic bronchitis, Productive cough with thick mucus, Pneumonia — adjunct mucolytic therapy. Available as 1 brand. Available without a prescription in Pakistan. Always confirm dose with a doctor or pharmacist.
What is Ambroxol?
Ambroxol is a mucolytic used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Ambroxol under multiple brand names — currently 1 listed on PakVita (1 syrup). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Mucolytic — thinning thick mucus (balgam) in acute and chronic bronchitis
- Productive cough with thick mucus
- Pneumonia — adjunct mucolytic therapy
- COPD — adjunct mucolytic to aid mucus clearance
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As directed on packaging — typically 10ml (30mg) three times daily; follow pack instructions or pharmacist advice
This is a general adult guidance pattern based on the manufacturer's label for one of the Ambroxol brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Nausea (matli)
- Vomiting
- Diarrhea (dast)
- Abdominal pain
- Rash (skin par lali — rarely)
Serious — stop and see a doctor
- Severe allergic reaction / anaphylaxis (rare — breathing difficulty, severe rash)
- Severe skin reactions — Stevens-Johnson syndrome (extremely rare, reported with mucolytic class)
Important warnings
- Not for dry or non-productive cough — mucolytic needs mucus to work
- Stay well hydrated for mucolytic to work effectively
- If cough persists more than 7 days — see a doctor; may indicate serious underlying condition
- Do not self-use any medicine during pregnancy — consult a pharmacist or doctor first
Conditions treated
Ambroxol brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Ambroxol used for in Pakistan?
Ambroxol is commonly used for Mucolytic — thinning thick mucus (balgam) in acute and chronic bronchitis, Productive cough with thick mucus, Pneumonia — adjunct mucolytic therapy, COPD — adjunct mucolytic to aid mucus clearance. It belongs to the mucolytic drug class.
What is the typical dosage of Ambroxol?
Typical adult dosing is described by manufacturers as: "As directed on packaging — typically 10ml (30mg) three times daily; follow pack instructions or pharmacist advice". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Ambroxol?
Common side effects include Nausea (matli), Vomiting, Diarrhea (dast), Abdominal pain, Rash (skin par lali — rarely). Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Ambroxol and see a doctor?
Stop Ambroxol and seek urgent medical care if you experience: Severe allergic reaction / anaphylaxis (rare — breathing difficulty, severe rash); Severe skin reactions — Stevens-Johnson syndrome (extremely rare, reported with mucolytic class). These are serious signs that need immediate attention.
Is Ambroxol available without a prescription in Pakistan?
Available without a prescription in Pakistan.
What brands of Ambroxol are available in Pakistan?
1 brand of Ambroxol is listed on PakVita: 1 syrup. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization